The phacoemulsification system market size has grown strongly in recent years. It will grow from $1.51 billion in 2025 to $1.63 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising cataract prevalence, aging population growth, adoption of phaco techniques, ophthalmic infrastructure expansion, surgeon preference for minimally invasive tools.
The phacoemulsification system market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in outpatient eye surgeries, technological innovation in ultrasound systems, rising demand for premium IOLs, expansion in emerging markets, increasing vision care awareness. Major trends in the forecast period include advanced fluidics control systems, minimally invasive cataract surgery adoption, high precision ultrasonic energy delivery, faster surgical procedure times, improved patient safety outcomes.
The increasing adoption of minimally invasive ophthalmic procedures is expected to propel the growth of the phacoemulsification system market going forward. Minimally invasive ophthalmic procedures refer to advanced eye care techniques that use small incisions, micro-instruments, or laser-based approaches to diagnose or treat eye conditions with minimal tissue disruption. The rise in minimally invasive ophthalmic procedures is due to the growing preference for faster recovery, as these techniques reduce surgical trauma and allow patients to resume daily activities much sooner. Phacoemulsification systems support minimally invasive ophthalmic procedures by using ultrasonic energy to break and remove the cataract through a tiny incision, enabling faster healing, reduced tissue damage, and improved surgical precision. For instance, in May 2024, according to Gov.UK, a UK-based government agency, there were 516,073 hospital admissions in England for cataract surgery among individuals aged 65 and above, representing a rate of 4,679 per 100,000 population in 2023. Therefore, the increasing adoption of minimally invasive ophthalmic procedures is driving the growth of the phacoemulsification system market.
Key companies operating in the phacoemulsification system market are focusing on integrating femtosecond laser technology, such as advanced fluidics concepts that maintain stable intraocular pressure (IOP), enhance chamber stability, and ensure consistent fluid control throughout all phases of cataract surgery, thereby improving surgical precision and patient safety. Advanced fluidics concepts refer to fluid management technologies in phacoemulsification systems that precisely regulate the balance between irrigation and aspiration during eye surgery. For instance, in September 2025, Beaver-Visitec International, Inc. (BVI), a US-based ophthalmic medical device company, introduced Virtuoso, a dual-function phaco-vitrectomy surgical platform designed for both cataract and vitreoretinal procedures. The system includes an innovative fluidics concept that maintains target intraocular pressure (IOP) during all surgical steps, a hybrid flow and pressure pump design for improved chamber stability, and Load Sensing Phaco technology that automatically adjusts ultrasound energy based on lens resistance to improve precision and surgical efficiency.
In January 2024, Rayner Group, a UK-based ophthalmic technology company, acquired This AG for an undisclosed amount. Through this acquisition, Rayner aims to strengthen its cataract-surgery portfolio by integrating advanced phaco-emulsification capabilities and expanding its presence in global surgical ophthalmology. This AG is a Switzerland-based ophthalmic technology company that develops phacoemulsification systems.
Major companies operating in the phacoemulsification system market are Alcon, Johnson & Johnson, Bausch + Lomb, NIDEK, Oertli Instrumente, Optikon, Geuder, Appasamy Associates, Biotech Visioncare, Meda, SIFI, Ziemer Ophthalmic Systems, Topcon, Carl Zeiss Meditec, Huvitz, Rumex International, DORC International, MicroSurgical Technology, LIGHTMED, Aurolab, MTP Medical Technical Products.
North America was the largest region in the phacoemulsification system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the phacoemulsification system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the phacoemulsification system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the phacoemulsification system market by increasing costs of ultrasonic components, precision electronics, and surgical consoles sourced globally. North America and Europe are most affected due to reliance on Asia-Pacific manufacturing hubs. These tariffs have slightly increased equipment prices and delayed procurement cycles. However, they are encouraging localized manufacturing, supplier diversification, and innovation in cost-efficient surgical platforms.
The phacoemulsification system market research report is one of a series of new reports that provides phacoemulsification system market statistics, including phacoemulsification system industry global market size, regional shares, competitors with a phacoemulsification system market share, detailed phacoemulsification system market segments, market trends and opportunities, and any further data you may need to thrive in the phacoemulsification system industry. This phacoemulsification system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Phacoemulsification systems are advanced medical devices that use ultrasonic energy to break up and remove the eye’s natural lens during cataract surgery, enabling the placement of an artificial intraocular lens (IOL) to restore clear vision. They are engineered to deliver precise control over fluidics, pressure, and energy output, ensuring safety, efficiency, and optimal surgical performance.
The primary product types of phacoemulsification systems include standalone phacoemulsification systems and portable phacoemulsification systems. Standalone phacoemulsification systems are fully integrated, stationary surgical units designed specifically for carrying out phacoemulsification procedures in ophthalmology. These systems employ various technologies - such as ultrasound, femtosecond laser, and others - to support a wide range of ophthalmic treatments. Key disease indications include cataract, presbyopia, glaucoma, and additional conditions. The primary applications for these systems are cataract surgery, refractive surgery, and other related procedures. They are utilized across multiple end users, including hospitals, ophthalmic clinics, ambulatory surgical centers, and other healthcare facilities.
The phacoemulsification systems market consists of sales of surgical equipment, consoles, handpieces, tubing sets, cassettes, and irrigation or aspiration components. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The phacoemulsification system market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in outpatient eye surgeries, technological innovation in ultrasound systems, rising demand for premium IOLs, expansion in emerging markets, increasing vision care awareness. Major trends in the forecast period include advanced fluidics control systems, minimally invasive cataract surgery adoption, high precision ultrasonic energy delivery, faster surgical procedure times, improved patient safety outcomes.
The increasing adoption of minimally invasive ophthalmic procedures is expected to propel the growth of the phacoemulsification system market going forward. Minimally invasive ophthalmic procedures refer to advanced eye care techniques that use small incisions, micro-instruments, or laser-based approaches to diagnose or treat eye conditions with minimal tissue disruption. The rise in minimally invasive ophthalmic procedures is due to the growing preference for faster recovery, as these techniques reduce surgical trauma and allow patients to resume daily activities much sooner. Phacoemulsification systems support minimally invasive ophthalmic procedures by using ultrasonic energy to break and remove the cataract through a tiny incision, enabling faster healing, reduced tissue damage, and improved surgical precision. For instance, in May 2024, according to Gov.UK, a UK-based government agency, there were 516,073 hospital admissions in England for cataract surgery among individuals aged 65 and above, representing a rate of 4,679 per 100,000 population in 2023. Therefore, the increasing adoption of minimally invasive ophthalmic procedures is driving the growth of the phacoemulsification system market.
Key companies operating in the phacoemulsification system market are focusing on integrating femtosecond laser technology, such as advanced fluidics concepts that maintain stable intraocular pressure (IOP), enhance chamber stability, and ensure consistent fluid control throughout all phases of cataract surgery, thereby improving surgical precision and patient safety. Advanced fluidics concepts refer to fluid management technologies in phacoemulsification systems that precisely regulate the balance between irrigation and aspiration during eye surgery. For instance, in September 2025, Beaver-Visitec International, Inc. (BVI), a US-based ophthalmic medical device company, introduced Virtuoso, a dual-function phaco-vitrectomy surgical platform designed for both cataract and vitreoretinal procedures. The system includes an innovative fluidics concept that maintains target intraocular pressure (IOP) during all surgical steps, a hybrid flow and pressure pump design for improved chamber stability, and Load Sensing Phaco technology that automatically adjusts ultrasound energy based on lens resistance to improve precision and surgical efficiency.
In January 2024, Rayner Group, a UK-based ophthalmic technology company, acquired This AG for an undisclosed amount. Through this acquisition, Rayner aims to strengthen its cataract-surgery portfolio by integrating advanced phaco-emulsification capabilities and expanding its presence in global surgical ophthalmology. This AG is a Switzerland-based ophthalmic technology company that develops phacoemulsification systems.
Major companies operating in the phacoemulsification system market are Alcon, Johnson & Johnson, Bausch + Lomb, NIDEK, Oertli Instrumente, Optikon, Geuder, Appasamy Associates, Biotech Visioncare, Meda, SIFI, Ziemer Ophthalmic Systems, Topcon, Carl Zeiss Meditec, Huvitz, Rumex International, DORC International, MicroSurgical Technology, LIGHTMED, Aurolab, MTP Medical Technical Products.
North America was the largest region in the phacoemulsification system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the phacoemulsification system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the phacoemulsification system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the phacoemulsification system market by increasing costs of ultrasonic components, precision electronics, and surgical consoles sourced globally. North America and Europe are most affected due to reliance on Asia-Pacific manufacturing hubs. These tariffs have slightly increased equipment prices and delayed procurement cycles. However, they are encouraging localized manufacturing, supplier diversification, and innovation in cost-efficient surgical platforms.
The phacoemulsification system market research report is one of a series of new reports that provides phacoemulsification system market statistics, including phacoemulsification system industry global market size, regional shares, competitors with a phacoemulsification system market share, detailed phacoemulsification system market segments, market trends and opportunities, and any further data you may need to thrive in the phacoemulsification system industry. This phacoemulsification system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Phacoemulsification systems are advanced medical devices that use ultrasonic energy to break up and remove the eye’s natural lens during cataract surgery, enabling the placement of an artificial intraocular lens (IOL) to restore clear vision. They are engineered to deliver precise control over fluidics, pressure, and energy output, ensuring safety, efficiency, and optimal surgical performance.
The primary product types of phacoemulsification systems include standalone phacoemulsification systems and portable phacoemulsification systems. Standalone phacoemulsification systems are fully integrated, stationary surgical units designed specifically for carrying out phacoemulsification procedures in ophthalmology. These systems employ various technologies - such as ultrasound, femtosecond laser, and others - to support a wide range of ophthalmic treatments. Key disease indications include cataract, presbyopia, glaucoma, and additional conditions. The primary applications for these systems are cataract surgery, refractive surgery, and other related procedures. They are utilized across multiple end users, including hospitals, ophthalmic clinics, ambulatory surgical centers, and other healthcare facilities.
The phacoemulsification systems market consists of sales of surgical equipment, consoles, handpieces, tubing sets, cassettes, and irrigation or aspiration components. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Phacoemulsification System Market Characteristics
3. Phacoemulsification System Market Supply Chain Analysis
4. Global Phacoemulsification System Market Trends and Strategies
5. Phacoemulsification System Market Analysis of End Use Industries
7. Global Phacoemulsification System Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Phacoemulsification System Total Addressable Market (TAM) Analysis for the Market
9. Phacoemulsification System Market Segmentation
10. Phacoemulsification System Market Regional and Country Analysis
11. Asia-Pacific Phacoemulsification System Market
12. China Phacoemulsification System Market
13. India Phacoemulsification System Market
14. Japan Phacoemulsification System Market
15. Australia Phacoemulsification System Market
16. Indonesia Phacoemulsification System Market
17. South Korea Phacoemulsification System Market
18. Taiwan Phacoemulsification System Market
19. South East Asia Phacoemulsification System Market
20. Western Europe Phacoemulsification System Market
21. UK Phacoemulsification System Market
22. Germany Phacoemulsification System Market
23. France Phacoemulsification System Market
24. Italy Phacoemulsification System Market
25. Spain Phacoemulsification System Market
26. Eastern Europe Phacoemulsification System Market
27. Russia Phacoemulsification System Market
28. North America Phacoemulsification System Market
29. USA Phacoemulsification System Market
30. Canada Phacoemulsification System Market
31. South America Phacoemulsification System Market
32. Brazil Phacoemulsification System Market
33. Middle East Phacoemulsification System Market
34. Africa Phacoemulsification System Market
36. Phacoemulsification System Market Competitive Landscape and Company Profiles
37. Phacoemulsification System Market Other Major and Innovative Companies
40. Phacoemulsification System Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Phacoemulsification System Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses phacoemulsification system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for phacoemulsification system? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The phacoemulsification system market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Standalone Phacoemulsification Systems; Portable Phacoemulsification Systems2) By Application: Cataract Surgery; Refractive Lens Exchange (RLE); Secondary Lens Removal Procedures
3) By End-User: Hospitals; Ophthalmic Clinics; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Standalone Phacoemulsification Systems: Ultrasonic Handpiece Units; Control Console Units; Fluid Management Units; Illumination Module Units2) By Portable Phacoemulsification Systems: Battery Powered Units; Compact Console Units; Handheld Operation Units; Mobile Surgical Kits
Companies Mentioned: Alcon; Johnson & Johnson; Bausch + Lomb; NIDEK; Oertli Instrumente; Optikon; Geuder; Appasamy Associates; Biotech Visioncare; Meda; SIFI; Ziemer Ophthalmic Systems; Topcon; Carl Zeiss Meditec; Huvitz; Rumex International; DORC International; MicroSurgical Technology; LIGHTMED; Aurolab; MTP Medical Technical Products
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Phacoemulsification System market report include:- Alcon
- Johnson & Johnson
- Bausch + Lomb
- NIDEK
- Oertli Instrumente
- Optikon
- Geuder
- Appasamy Associates
- Biotech Visioncare
- Meda
- SIFI
- Ziemer Ophthalmic Systems
- Topcon
- Carl Zeiss Meditec
- Huvitz
- Rumex International
- DORC International
- MicroSurgical Technology
- LIGHTMED
- Aurolab
- MTP Medical Technical Products
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.63 Billion |
| Forecasted Market Value ( USD | $ 2.16 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
